Cardiovascular magnetic resonance imaging (CMR): Difference between revisions
No edit summary |
No edit summary |
||
| Line 38: | Line 38: | ||
evaluating individuals with heart failure. | evaluating individuals with heart failure. | ||
}} | }} | ||
*CMR in [[Coronary artery disease]] | |||
==ACC/AHA Guidelines- Name of Guidelines Topic Goes Here (DO NOT EDIT)== | |||
{{cquote| | |||
CMR may be used for identifying coronary artery anomalies and aneurysms and for determining coronary artery patency. In specialized | |||
centers, CMR may be uniquely useful in identifying patients with multivessel coronary artery disease without exposure to ionizing | |||
radiation or iodinated contrast medium. | |||
}} | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 04:58, 1 October 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Eli V. Gelfand, M.D.[2]; Caitlin J. Harrigan [3]
Overview
- CMR-Related Definitions
- ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 Appropriateness Criteria for Cardiac Magnetic Resonance Imaging
- ACR Practice Guideline for the Performance and Interpretation of Cardiac Magnetic Resonance Imaging (MRI)
- Basic MRI Physics
- CMR Image Acquisition Protocols
- Standard Image Orientation
- Normal Cardiac Anatomy as Viewed by CMR
- Contrast CMR
- Cine CMR
- Myocardial Tagging
- Flow Quantification by CMR
- Ischemic Heart Disease: Perfusion, Late Gadolinium Enhancement
- CMR in Valvular Heart Disease
- CMR in Dilated Cardiomyopathy
- CMR in Hypertrophic Cardiomyopathy
- CMR in Cardiac Masses
- CMR in Pericardial Disease
- CMR in Congenital Disease
- CMR in Athlete's Heart
- CMR in Cardiac Sarcoidosis
- CMR in Cardiac Amyloidosis
- CMR in Hemochromotosis
- Coronary MRI
- Peripheral Vascular MRA
- Atherosclerosis/Plaque Imaging with CMR
- CMR Risk Factors: NSF
- CMR in Heart failure
ACC/AHA Guidelines- Name of Guidelines Topic Goes Here (DO NOT EDIT)
| “ |
CMR may be used for assessment of LV and RV size and morphology, systolic and diastolic function, and for characterizing myocardial tissue for the purpose of understanding the etiology of LV systolic or diastolic dysfunction. The writing committee recognizes the potential capabilities of spectroscopic techniques for acquiring metabolic information of the heart when evaluating individuals with heart failure. |
” |
- CMR in Coronary artery disease
ACC/AHA Guidelines- Name of Guidelines Topic Goes Here (DO NOT EDIT)
| “ |
CMR may be used for identifying coronary artery anomalies and aneurysms and for determining coronary artery patency. In specialized centers, CMR may be uniquely useful in identifying patients with multivessel coronary artery disease without exposure to ionizing radiation or iodinated contrast medium. |
” |